← Dashboard
Sep 23, 2026 02:38 PM ET
Catalyst
FDA/Bio
STRONG EARNINGS, FDA APPROVAL, AND TAKEOVER INTEREST DRIVE LANTHEUS HOLDINGS’ (LNTH) RALLY - YAHOO
Earnings, FDA approval, and takeover interest are cited catalysts driving the rally.
What changed
Earnings, FDA approval, and takeover interest are cited catalysts driving the rally.
Why it matters
Earnings, FDA approval, and takeover interest are cited catalysts driving the rally. — impact context not separately stored; see What changed.
Sources
yahoo
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →